Patents by Inventor Joachim Kuhnke

Joachim Kuhnke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the production of 4,4-dimethyl-5&agr;-cholesta-8,14,24-trien-3&bgr;-01 and intermediate products in process (I)
    Patent number: 6683197
    Abstract: The subject of this invention is a new process with variant embodiments for the production of compound 1.
    Type: Grant
    Filed: April 9, 1999
    Date of Patent: January 27, 2004
    Assignee: Schering Aktiengesellschaft
    Inventors: Thorsten Blume, Peter Esperling, Joachim Kuhnke
  • Microglia inhibitors for interrupting interleukin 12 and IFN-gamma-mediated immune reactions
    Publication number: 20040006117
    Abstract: The invention describes the use of microglia inhibitors for the production of pharmaceutical agents that inhibit immune reactions that are mediated by monocytes, macrophages and T cells, and their use for treating T-cell-mediated immunological diseases and non-T-cell-mediated inflammation reactions.
    Type: Application
    Filed: February 14, 2003
    Publication date: January 8, 2004
    Applicant: SCHERING AKTIENGESELLSCHAFT
    Inventors: Thorsten Blume, Wolf-Dietrich Doecke, Wolfgang Halfbrodt, Joachim Kuhnke, Ursula Moenning, Bernd Elger, Herbert Schneider
  • 1-Phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
    Publication number: 20030229085
    Abstract: New benzimidazole derivatives are described, their production and their use for the production of pharmaceutical agents for treatment and prevention of diseases that are associated with a microglia activation and T-cell-mediated immunological diseases, as well as pharmaceutical preparations that contain the new benzimidazole derivatives.
    Type: Application
    Filed: February 14, 2003
    Publication date: December 11, 2003
    Applicant: Schering Aktiengesellschaft
    Inventors: Thorsten Blume, Wolfgang Halfbrodt, Joachim Kuhnke, Ursula Moenning, Bernd Elger, Herbert Schneider
  • 1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
    Publication number: 20030125550
    Abstract: The invention relates to novel benzimidazole derivatives with general formula I, whereby radicals R1, R2, R3, A, B, Y and Z have the meanings that are indicated in the description and the claims, the use of these compounds for the production of a pharmaceutical agent for treatment and prevention of diseases associated with microglia activation as well as pharmaceutical preparations that contain these compounds.
    Type: Application
    Filed: July 9, 2002
    Publication date: July 3, 2003
    Inventors: Thorsten Blume, Wolfgang Halfbrodt, Joachim Kuhnke, Ursula Monning, Herbert Schneider
  • 1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutial agents as well as pharmaceutical preparations that contain these derivatives
    Publication number: 20030055057
    Abstract: The invention relates to novel benzimidazole derivatives with general formula I, whereby radicals R1, R2, R3, A, B and Y have the meanings that are indicated in the description and the claims, the use of these compounds for the production of a pharmaceutical agent for treating and for preventing diseases that are associated with microglia activation, as well as pharmaceutical preparations that contain these compounds.
    Type: Application
    Filed: July 5, 2002
    Publication date: March 20, 2003
    Applicant: Schering AG
    Inventors: Thorsten Blume, Wolfgang Halfbrodt, Joachim Kuhnke, Ursula Moenning, Herbert Schneider, Bernd Elger
  • 1,2 diarylbenzimdazoles and their pharmaceutical use
    Publication number: 20020006948
    Abstract: Benzimidazoles of general formula I 1
    Type: Application
    Filed: January 16, 2001
    Publication date: January 17, 2002
    Applicant: Schering AG
    Inventors: Wolfgang Halfbrodt, Joachim Kuhnke, Ursula Moenning
  • 14-.alpha., 17-.alpha.-C.sub.2 bridged norprogesterone derivatives
    Patent number: 6147065
    Abstract: Described are 14,17-C.sub.2 -bridged steroids of the formula (I) defined in the specification. The compounds are available, even after peroral administration, with high gestagenic action and are suitable for the production of pharmaceutical agents.
    Type: Grant
    Filed: July 28, 1999
    Date of Patent: November 14, 2000
    Assignee: Schering Aktiengesellschaft
    Inventors: Klaus Schollkopf, Wolfgang Halfbrodt, Joachim Kuhnke, Wolfgang Schwede, Karl-Heinrich Fritzemeier, Rolf Krattenmacher, Hans-Peter Muhn
  • 14-.alpha.,17-.alpha.-C.sub.2 -bridged norprogesterone derivatives
    Patent number: 5973172
    Abstract: The invention describes 14,17-C.sub.2 -bridged steroids of general formula (I), ##STR1## wherein the various R groups are as defined in the specification, and wherein said steroids are in contrast, with the disclaimed compound, the new compounds are available even after peroral administration with high gestagenic action and are suitable for the production of pharmaceutical agents.
    Type: Grant
    Filed: August 18, 1998
    Date of Patent: October 26, 1999
    Assignee: Schering Akitengesellschaft
    Inventors: Klaus Schollkopf, Wolfgang Halfbrodt, Joachim Kuhnke, Wolfgang Schwede, Karl-Heinrich Fritzemeier, Rolf Krattenmacher, Hans-Peter Muhn
  • 14.alpha., 17.alpha.-C.sub.2 -bridged norprogesterone derivatives
    Patent number: 5827842
    Abstract: The invention describes 14,17-C.sub.2 -bridged steroids of general formula (I), ##STR1## wherein the various R groups are as defined in the specification, and wherein said steroids are, in contrast with the disclaimed compound 14,17-ethano-19-norpregn-4-ene-3,20-dione bioavailable even after peroral administration with high gestagenic action and are suitable for the production of pharmaceutical agents.
    Type: Grant
    Filed: December 26, 1995
    Date of Patent: October 27, 1998
    Assignee: Schering Aktiengesellschaft
    Inventors: Klaus Schollkopf, Wolfgang Halfbrodt, Joachim Kuhnke, Wolfgang Schwede, Karl-Heinrich Fritzemeier, Rolf Krattenmacher, Hans-Peter Muhn